- Citations, last 5 years
- 25
- Works, last 5 years
- 4
- h-index
- 56
- Scientists listed
- 0
- Grants since 2016
- 12
Grants received
2022–2024 · research · R43
Off-the-shelf engineered NK cells to treat glioblastoma
Joe Trebley · BioVentures (United States) · funded by National Institutes of Health
2019–2022 · research · R44
Soluble, solution-stable phospho-glucagon for hypoglycemic rescue
Mark Louis Heiman · BioVentures (United States) · funded by National Institutes of Health
2019–2020 · research · R44
Soluble, solution-stable phospho-glucagon for hypoglycemic rescue
Mark Louis Heiman · BioVentures (United States) · funded by National Institutes of Health
2019–2023 · research · R44
Soluble, solution-stable phospho-glucagon for hypoglycemic rescue
Mark Louis Heiman · BioVentures (United States) · funded by National Institutes of Health
2017–2020 · research · R42
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
Nicholas M Adams · BioVentures (United States) · funded by National Institutes of Health
2017–2020 · research · R42
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
Nicholas M Adams · BioVentures (United States) · funded by National Institutes of Health
2017–2018 · research · R43
Artificially Intelligent Diabetes Assistant (AIDA) for African Americans with Type 2 Diabetes
Mark Brian Mcnasby · BioVentures (United States) · funded by National Institutes of Health
2017 · research · R42
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
Nicholas M Adams · BioVentures (United States) · funded by National Institutes of Health
2017–2019 · research · R42
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
Nicholas M Adams · BioVentures (United States) · funded by National Institutes of Health
2017–2021 · research · R42
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
Nicholas M Adams · BioVentures (United States) · funded by National Institutes of Health
2017–2019 · research · R41
A Novel Probiotic Platform to Treat Necrotizing Enterocolitis
Gail E Besner · BioVentures (United States) · funded by National Institutes of Health
2017–2019 · research · R43
Artificially Intelligent Diabetes Assistant (AIDA) for African Americans with Type 2 Diabetes
Mark Brian Mcnasby · BioVentures (United States) · funded by National Institutes of Health
